(Q35844057)

English

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals

scientific article published on 7 November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax challenge in vaccinia-naïve and vaccinia-immune individuals (English)

1 reference

Europe PubMed Central

10 August 2017

Barney S. Graham

13

object named as

Barney S Graham

1 reference

Europe PubMed Central

10 August 2017

8

object named as

Mario Roederer

1 reference

Europe PubMed Central

10 August 2017

6

object named as

Mary E Enama

1 reference

Europe PubMed Central

10 August 2017

Ingelise J Gordon

4

object named as

Ingelise J Gordon

1 reference

Europe PubMed Central

10 August 2017

7

object named as

Richard A Koup

1 reference

Europe PubMed Central

10 August 2017

10

object named as

Zoe Moodie

1 reference

Europe PubMed Central

10 August 2017

author name string

Janie Parrino

1

1 reference

Europe PubMed Central

10 August 2017

Lewis H McCurdy

2

1 reference

Europe PubMed Central

10 August 2017

Brenda D Larkin

3

1 reference

Europe PubMed Central

10 August 2017

Steven E Rucker

5

1 reference

Europe PubMed Central

10 August 2017

Robert T Bailer

9

1 reference

Europe PubMed Central

10 August 2017

Lin Gu

11

1 reference

Europe PubMed Central

10 August 2017

Lihan Yan

12

1 reference

Europe PubMed Central

10 August 2017

VRC 201/203 Study Team

14

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

7 November 2006

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

25

1 reference

Europe PubMed Central

10 August 2017

8

1 reference

Europe PubMed Central

10 August 2017

1513-1525

1 reference

Europe PubMed Central

10 August 2017

Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Modified vaccinia virus Ankara immunization protects against lethal challenge with recombinant vaccinia virus expressing murine interleukin-4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Modified vaccinia Ankara: potential as an alternative smallpox vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Highly attenuated smallpox vaccine protects mice with and without immune deficiencies against pathogenic vaccinia virus challenge

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Evaluation of 21st-century risks of smallpox vaccination and policy options

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Threats in bioterrorism. I: CDC category A agents

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Smallpox as a Biological Weapon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Vaccination of vaccinia-naive adults with human immunodeficiency virus type 1 gp160 recombinant vaccinia virus in a blinded, controlled, randomized clinical trial. The AIDS Vaccine Clinical Trials Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

11 July 2018

Extended interhuman transmission of monkeypox in a hospital community in the Republic of the Congo, 2003.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

24 September 2018

Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

24 September 2018

Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised macaques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

24 September 2018

Safety of modified vaccinia virus Ankara (MVA) in immune-suppressed macaques.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1892755

24 September 2018

Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.047

7 January 2021

Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.047

7 January 2021

Myopericarditis following smallpox vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.10.047

7 January 2021

Safety and immunogenicity of new cell-cultured smallpox vaccine compared with calf-lymph derived vaccine: a blind, single-centre, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/17126963

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/J.VACCINE.2006.10.047

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35844057&oldid=1601971280"